Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1988 | 12-1987 | 12-1986 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 13,561 | 5,919 | 12,021 |
| Marketable Securities | 8,592 | 20,519 | 10,045 |
| Receivables | 0 | 0 | 86 |
| Other current assets | 119 | 174 | 43 |
| TOTAL | $22,272 | $26,612 | $22,195 |
| Non-Current Assets | |||
| PPE Net | 3,241 | 3,559 | 1,244 |
| Other Non-Current Assets | 38 | 38 | 0 |
| TOTAL | $3,280 | $3,597 | $1,244 |
| Total Assets | $25,552 | $30,209 | $23,439 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 433 | 215 | 70 |
| Accrued Expenses | 565 | 583 | 711 |
| Other current liabilities | 69 | 13 | 218 |
| TOTAL | $1,067 | $811 | $999 |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $1,067 | $811 | $999 |
| Shareholders' Equity | |||
| Common Shares | 53 | 52 | 41 |
| Retained earnings | -11,679 | -6,731 | -2,384 |
| Other shareholders' equity | -193 | 0 | 1 |
| TOTAL | $24,485 | $29,398 | $22,440 |
| Total Liabilities And Equity | $25,552 | $30,209 | $23,439 |